Close

Maxim Positive on Onconova Therapeutics (ONTX) Following Q2 Report; Notes Accelerating INSPIRE Enrollment

Go back to Maxim Positive on Onconova Therapeutics (ONTX) Following Q2 Report; Notes Accelerating INSPIRE Enrollment

Onconova Therapeutics (ONTX) Reports Q2 Loss of $1.96/Share

August 15, 2016 7:02 AM EDT

Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($1.96), versus ($4.13) reported last year. Revenue for the quarter came in at $2.25 million, versus $123 thousand reported last year.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

... More